← back to search

Richard W. Compans

Emory University · US
Area of research
Epidemiology · Virology
Research interest
Research interests include Influenza Virus Research Studies, Respiratory viral infections research, HIV Research and Treatment, and Virology and Viral Diseases.
h-index
95
citations
34,618
works
526
NIH funding
primary concept
email

Recent publications

Intranasal vaccination with influenza HA/GO-PEI nanoparticles provides immune protection against homo- and heterologous strains
Proceedings of the National Academy of Sciences 2021cited by 68position: middledoi
cGAMP/Saponin Adjuvant Combination Improves Protective Response to Influenza Vaccination by Microneedle Patch in an Aged Mouse Model
Frontiers in Immunology 2021cited by 26position: lastdoi
Bivalent vaccination with NA1 and NA2 neuraminidase virus-like particles is protective against challenge with H1N1 and H3N2 influenza A viruses in a murine model
Virology 2021cited by 10position: middledoi
Extended delivery of vaccines to the skin improves immune responses
Journal of Controlled Release 2019cited by 34position: middledoi
Combination of STING Pathway Agonist With Saponin Is an Effective Adjuvant in Immunosenescent Mice
Frontiers in Immunology 2019cited by 32position: lastdoi
NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines?
mBio 2018cited by 303position: middledoi
Double-layered protein nanoparticles induce broad protection against divergent influenza A viruses
Nature Communications 2018cited by 191position: middledoi
Heterosubtypic influenza protection elicited by double-layered polypeptide nanoparticles in mice
Proceedings of the National Academy of Sciences 2018cited by 96position: middledoi
Stable incorporation of GM-CSF into dissolvable microneedle patch improves skin vaccination against influenza
Journal of Controlled Release 2018cited by 46position: middledoi
Intradermal immunization by Ebola virus GP subunit vaccines using microneedle patches protects mice against lethal EBOV challenge
Scientific Reports 2018cited by 29position: middledoi
The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial
The Lancet 2017cited by 420position: middledoi
H1N1 influenza virus infection results in adverse pregnancy outcomes by disrupting tissue-specific hormonal regulation
PLoS Pathogens 2017cited by 119position: middledoi
Chimeric virus-like particles containing influenza HA antigen and GPI-CCL28 induce long-lasting mucosal immunity against H3N2 viruses
Scientific Reports 2017cited by 24position: middledoi
Long-term stability of influenza vaccine in a dissolving microneedle patch
Drug Delivery and Translational Research 2016cited by 145position: middledoi
Ebola Vaccination Using a DNA Vaccine Coated on PLGA‐PLL/γPGA Nanoparticles Administered Using a Microneedle Patch
Advanced Healthcare Materials 2016cited by 118position: middledoi
Tetanus vaccination with a dissolving microneedle patch confers protective immune responses in pregnancy
Journal of Controlled Release 2016cited by 59position: middledoi
Production of Potent Fully Human Polyclonal Antibodies against Ebola Zaire Virus in Transchromosomal Cattle
Scientific Reports 2016cited by 43position: middledoi
Coated protein nanoclusters from influenza H7N9 HA are highly immunogenic and induce robust protective immunity
Nanomedicine Nanotechnology Biology and Medicine 2016cited by 34position: middledoi
Enhanced Stability of Inactivated Influenza Vaccine Encapsulated in Dissolving Microneedle Patches
Pharmaceutical Research 2015cited by 94position: middledoi
Improved immunogenicity of individual influenza vaccine components delivered with a novel dissolving microneedle patch stable at room temperature
Drug Delivery and Translational Research 2015cited by 90position: middledoi
Enhanced immune responses by skin vaccination with influenza subunit vaccine in young hosts
Vaccine 2015cited by 41position: lastdoi
Protein transfer-mediated surface engineering to adjuvantate virus-like nanoparticles for enhanced anti-viral immune responses
Nanomedicine Nanotechnology Biology and Medicine 2015cited by 27position: middledoi
Incorporation of a GPI-anchored engineered cytokine as a molecular adjuvant enhances the immunogenicity of HIV VLPs
Scientific Reports 2015cited by 27position: middledoi
Characterization of Immune Responses Induced by Ebola Virus Glycoprotein (GP) and Truncated GP Isoform DNA Vaccines and Protection Against Lethal Ebola Virus Challenge in Mice
The Journal of Infectious Diseases 2015cited by 26position: middledoi
Microneedle delivery of an M2e-TLR5 ligand fusion protein to skin confers broadly cross-protective influenza immunity
Journal of Controlled Release 2014cited by 75position: lastdoi
Emergence and Evolution of Avian H5N2 Influenza Viruses in Chickens in Taiwan
Journal of Virology 2014cited by 73position: middledoi
Influenza Virus-Specific Neutralizing IgM Antibodies Persist for a Lifetime
Clinical and Vaccine Immunology 2014cited by 67position: middledoi
Universal Influenza Vaccines, a Dream to Be Realized Soon
Viruses 2014cited by 65position: middledoi
Influenza Pathogenesis and Control - Volume I
Current topics in microbiology and immunology 2014cited by 56position: firstdoi
Supplementation of Influenza Split Vaccines with Conserved M2 Ectodomains Overcomes Strain Specificity and Provides Long-term Cross Protection
Molecular Therapy 2014cited by 52position: middledoi

Grants

Structural Components of Viral Membranes
NSF8006498$100,0001980–1984PIRePORTER
Structural Components of Viral Membranes
NSF7809207$96,5061978–1981PIRePORTER
Structural Components of Viral Membranes
NSF7609711$50,0001976–1978PIRePORTER
Viral Membrane Structure and Virus-Induced Alterations in Cell Surfaces
NSF7518199$5,0001975–1976PIRePORTER

Frequent collaborators

Mark R. Prausnitz · Georgia Institute of Technology22 papers (2012–2021)Sang‐Moo Kang · Georgia State University20 papers (2012–2021)Ioanna Skountzou · Emory University16 papers (2012–2021)Bao‐Zhong Wang · North China University of Science and Technology14 papers (2012–2021)Elena V. Vassilieva · Georgia Institute of Technology11 papers (2012–2021)E. Stein Esser · Emory University10 papers (2012–2019)Chinglai Yang · Emory University9 papers (2012–2018)Jae-Min Song · Sungshin Women's University8 papers (2012–2015)Fu‐Shi Quan · Jilin University8 papers (2012–2014)Li Wang · Hebei Medical University6 papers (2012–2016)Shelly Wang · Emory University6 papers (2015–2021) · 6 papers (2012–2018)Dimitrios G. Koutsonanos · Emory Healthcare5 papers (2012–2015)Dae‐Goon Yoo · Washington University in St. Louis4 papers (2012–2013)Wenfang Li · Xinjiang University4 papers (2012–2016)Yeu‐Chun Kim · Korea Advanced Institute of Science and Technology4 papers (2012–2013)Timothy Z. Chang · Georgia Institute of Technology4 papers (2013–2018) · 3 papers (2012–2013)Joshy Jacob · Emory University3 papers (2012–2016)Han Zhang · Sun Yat-sen University3 papers (2014–2015)